While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

The Centre is a collaboration between the ICR and The Royal Marsden NHS Foundation Trust driving pioneering research for ...

Immutep (ASX:IMM) has announced promising new data from its Phase IIb TACTI-003 trial, presented at the ESMO Immuno-Oncology Congress 2024.

Reality star Turner, 73, shocked the world when he and Nist, 71, announced their split after just three months of marriage in ...

Golden Bachelor star Gerry Turner has revealed he was diagnosed with incurable cancer weeks before his April split from ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the American Society of Hematology meeting in San Diego.

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...

Candel Therapeutics' CAN-2409 shows a 14.5% improvement in prostate cancer survival. Discover why CADL stock stays a "Buy" ...

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral ...

EIGHT women who had their smear tests misread by screeners went on to develop cancer, a major review has found. Eleven more were found to have pre-cancerous changes to cells and needed treatment ...

BriaCell successfully identified immunogenic (i.e. immune system activating) peptides in patients treated with Bria-IMT™, a cell-based cancer vaccine, and showed Bria-IMT™'s ability to produce a ...